6714 NW 16th Street, Suite B
Gainesville, FL 32653
June 3, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, DC 20549
Attention: Doris Stacey Gama
|
Re: |
Cyclo Therapeutics, Inc. |
||
|
Registration Statement on Form S-3 |
|||
|
Filed May 24, 2024 |
|||
|
File No. 333-279703 Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cyclo Therapeutics, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 5:00 p.m., Eastern Time, on June 4, 2024, or as soon thereafter as is practicable.
The Company requests that it be notified of such effectiveness by a telephone call to Sarah Hewitt of Fox Rothschild LLP at (212) 878-1435.
Thank you for your assistance in this matter. Should you have any questions, please call Ms. Hewitt.
|
Very truly yours, |
|
/s/ N. Scott Fine |
|
N. Scott Fine |
|
Chief Executive Officer |
cc: Sarah Hewitt, Esq.